Paladin Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Hold |
1,356
| – | – | 0.08% | 109 |
|
|
2025
Q1 | $98.3K | Hold |
1,356
| – | – | 0.08% | 108 |
|
|
2024
Q4 | $100K | Hold |
1,356
| – | – | 0.08% | 114 |
|
|
2024
Q3 | $89.5K | Hold |
1,356
| – | – | 0.07% | 122 |
|
|
2024
Q2 | $122K | Hold |
1,356
| – | – | 0.1% | 105 |
|
|
2024
Q1 | $128K | Hold |
1,356
| – | – | 0.1% | 105 |
|
|
2023
Q4 | $103K | Hold |
1,356
| – | – | 0.09% | 111 |
|
|
2023
Q3 | $93.9K | Hold |
1,356
| – | – | 0.08% | 121 |
|
|
2023
Q2 | $128K | Hold |
1,356
| – | – | 0.1% | 111 |
|
|
2023
Q1 | $112K | Buy |
+1,356
| New | +$112K | 0.09% | 119 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 77 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 77 |
|
|
2022
Q2 | – | Sell |
-1,356
| Closed | -$166K | – | 79 |
|
|
2022
Q1 | $166K | Buy |
+1,356
| New | +$166K | 0.14% | 104 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 74 |
|